Sinopharm Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CNE100000FN7
HKD
20.92
0.42 (2.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.83 M

Shareholding (Dec 2024)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt Company with a Debt to Equity ratio (avg) at times

  • High Debt Company with a Debt to Equity ratio (avg) at times
2

High Debt company with Weak Long Term Fundamental Strength

 
3

Negative results in Jun 25

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

HKD 65,471 Million ()

stock-summary
P/E

2.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.32%

stock-summary
Debt Equity

0.96

stock-summary
Return on Equity

12.98%

stock-summary
Price to Book

0.74

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.03%
0%
6.03%
6 Months
11.81%
0%
11.81%
1 Year
13.7%
0%
13.7%
2 Years
2.8%
0%
2.8%
3 Years
-11.92%
0%
-11.92%
4 Years
16.74%
0%
16.74%
5 Years
7.84%
0%
7.84%

Sinopharm Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
5.58%
EBIT Growth (5y)
-0.84%
EBIT to Interest (avg)
5.74
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
3.03
Tax Ratio
27.95%
Dividend Payout Ratio
30.17%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
18.45%
ROE (avg)
19.69%

Valuation key factors

Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.30
EV to EBIT
3.87
EV to EBITDA
3.04
EV to Capital Employed
0.55
EV to Sales
0.11
PEG Ratio
NA
Dividend Yield
8.68%
ROCE (Latest)
14.25%
ROE (Latest)
14.39%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sinopharm Group Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.86% vs 2.67% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -31.86% vs -0.58% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "633,737.40",
          "val2": "659,208.20",
          "chgp": "-3.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23,886.90",
          "val2": "28,896.40",
          "chgp": "-17.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3,193.30",
          "val2": "3,507.00",
          "chgp": "-8.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,161.90",
          "val2": "111.70",
          "chgp": "-1,140.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,301.50",
          "val2": "16,585.80",
          "chgp": "-31.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.60%",
          "val2": "36.40%",
          "chgp": "-0.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
633,737.40
659,208.20
-3.86%
Operating Profit (PBDIT) excl Other Income
23,886.90
28,896.40
-17.34%
Interest
3,193.30
3,507.00
-8.94%
Exceptional Items
-1,161.90
111.70
-1,140.20%
Consolidate Net Profit
11,301.50
16,585.80
-31.86%
Operating Profit Margin (Excl OI)
29.60%
36.40%
-0.68%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -3.86% vs 2.67% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -31.86% vs -0.58% in Dec 2023

stock-summaryCompany CV
About Sinopharm Group Co., Ltd. stock-summary
stock-summary
Sinopharm Group Co., Ltd.
Retailing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available